Treatment for 7-OH, MGM Products & Pseudoindoxyl
Access to 7-OH, pseudoindoxyl, MGM products, SR-17018, and related products is changing rapidly. You’re not alone—and help is available.
Dr. James B. Watson, DO provides private, office-based and telemedicine treatment for substance use disorder involving these and other opioid-like products—serving patients in Norristown and throughout Pennsylvania.
How to Get Off 7-OH: Create a Plan, Come Ready to Change, Know Your Goal
Dr. James B. Watson, DO explains how to get off 7-OH, why having a plan matters, and how medical treatment can help you reach your goal.
Treatment for 7-OH, Kratom & Emerging Opioid-Like Products
Whether you’re dealing with substance use disorder, withdrawal, cravings, tolerance, or difficulty stopping, treatment is available.
These products aren’t all the same. Traditional kratom, concentrated 7-OH products, and newer kratom-derived compounds can differ in potency and effects. Understanding what you’re taking—and how it’s affecting you—helps guide a more effective, individualized treatment plan and explains why a 7-OH withdrawal timeline cannot reliably fit everyone.
7-OH / 7-Hydroxymitragynine
Concentrated 7-OH products can produce opioid-like effects and may be associated with substance use disorder, tolerance, withdrawal, cravings, and difficulty stopping.
Kratom & Kratom Extracts
Substance use disorder can develop with kratom itself, including powders, extracts, enhanced products, and other concentrated preparations.
Pseudoindoxyl & MGM Products
Newer Kratom-Derived ProductsMitragynine pseudoindoxyl, MGM-15, MGM-16, and related compounds are newer kratom-derived products whose potency and effects can differ significantly from traditional kratom.
Tianeptine & Other Gas Station Products
We evaluate and treat substance use disorder involving tianeptine and other emerging opioid-like products sold through smoke shops, convenience stores, and online suppliers.
Effective Treatment Is Available.
Treatment is individualized to the substance you’re using, your symptoms, your medical history, and your goals. Dr. Watson provides comprehensive addiction treatment that can include medication-assisted treatment and other medical approaches when appropriate.
Still Feeling Withdrawal After Trying to Get Off 7-OH?
7-OH and related products may affect more than one receptor system. That can help explain why some people continue to feel symptomatic even after addressing the opioid component.
What’s Changing Now
Recent federal actions affect several newer kratom-derived compounds and synthetic opioids. Some substances have now been temporarily placed into Schedule I, while federal action involving concentrated 7-OH is still developing.
Pseudoindoxyl • MGM-15 • MGM-16
Effective August 26, 2026The DEA temporarily placed mitragynine pseudoindoxyl, MGM-15, and MGM-16 into Schedule I.
This action applies to these specified compounds. It is not the same as federally scheduling traditional botanical kratom.
SR-17018 & Related Synthetic Opioids
Effective August 27, 2026SR-17018 and several related synthetic opioids were addressed through a separate DEA temporary Schedule I action.
Some people had been using or considering SR-17018 as a way to taper or manage withdrawal from other opioid-like products. That option has now changed, but established medical treatment remains available.
7-OH / 7-Hydroxymitragynine
Federal action involving elevated or concentrated 7-OH is moving through a separate process.
The DEA has announced its intent to temporarily schedule 7-OH above a specified threshold, while federal review of that threshold has continued.
This is not the same as saying botanical kratom itself has been federally scheduled.
Has the product you were using suddenly changed or become unavailable?
The regulatory landscape may have changed. Your treatment options haven’t disappeared. Established medical treatment for substance use disorder remains available.
Treatment is about more than simply getting through withdrawal. Dr. Watson provides ongoing, individualized medical care focused on stability, control, recovery, and helping treatment fit into your life.
A Medical Alternative You May Not Have Known Existed
Many people using 7-OH, kratom extracts, pseudoindoxyl, MGM products, tianeptine, or other products sold through smoke shops, vape shops, gas stations, and online suppliers never thought of themselves as someone who needed “rehab.”
Some began using these products to manage pain, withdrawal, cravings, or an existing substance use disorder—or because the products were accessible and seemed easier to manage while continuing to work and live their normal lives.
As products become more concentrated and substance use disorder develops, stopping can become increasingly difficult.
There is another option.Dr. Watson provides private, office-based medical treatment for substance use disorder that is designed to fit into everyday life—not replace it.
You can receive high-level addiction treatment without putting your life on hold.
Effective Treatment
Evidence-based medications and medical treatment can help reduce withdrawal, cravings, instability, and repeated cycles of stopping and restarting.
Designed Around Your Life
Treatment is structured so many patients can continue working, caring for family, traveling, and living their normal lives while receiving medical care.
Private & Discreet
Care is provided through a private medical office rather than a large treatment facility, with telemedicine available throughout Pennsylvania when appropriate.
Affordable & Accessible
Many insurance plans are accepted, with affordable direct-pay options available for patients who prefer or need another way to access care.
Our goal isn’t simply to get you through withdrawal. It’s to help you achieve lasting stability, control, and recovery—so treatment can move into the background and you can get on with your life.
How Long Does 7-OH Withdrawal Last?
You may find 7-OH withdrawal timelines online telling you when withdrawal should begin, when symptoms should peak, and how many hours you should wait before starting buprenorphine. Those timelines can provide general context—but they cannot reliably predict what will happen to every individual.
There is no standardized 7-OH product. So how can there be one standardized timeline?
Don’t Just Watch the Clock.
Traditional buprenorphine induction has never been based solely on how many hours have passed. It is based on actually being in opioid withdrawal.
That’s why we still use the Clinical Opiate Withdrawal Scale (COWS) to measure withdrawal symptoms and help determine when someone is ready to start.
If you’re transitioning from 7-OH to buprenorphine and trying to avoid precipitated withdrawal, an addiction specialist can evaluate what you’ve been taking, your withdrawal history, and what your symptoms look like now.
Questions About 7-OH, Kratom & Treatment
These are some of the most common questions people have about 7-OH, kratom-derived products, recent DEA actions, and medical treatment for substance use disorder.
As of August 31, 2026, the federal actions involving 7-OH (7-hydroxymitragynine) need to be distinguished from the separate temporary Schedule I actions involving other compounds.
The DEA has announced its intent to temporarily schedule concentrated 7-OH above a specified threshold, while that federal process continues. This is different from saying that traditional botanical kratom itself has been federally placed into Schedule I.
Separately, compounds including mitragynine pseudoindoxyl, MGM-15, MGM-16, and SR-17018 have been affected by recent temporary Schedule I actions.
Yes. Dr. Watson provides individualized medical treatment for substance use disorder involving 7-OH, kratom and kratom extracts, pseudoindoxyl, MGM products, tianeptine, and other opioid-like products.
Treatment depends on what you are using, your symptoms, medical history, prior treatment, and your goals.
Yes. When medically appropriate, Suboxone or other forms of buprenorphine may be part of an individualized treatment plan.
Long-acting buprenorphine options such as Sublocade and Brixadi may also be considered when appropriate.
Not everyone with a substance use disorder requires residential treatment. Many people can be treated effectively through a private, office-based medical practice.
If a higher level of care is medically appropriate, that should be discussed as part of the treatment evaluation.
Often, yes. Office-based addiction treatment is designed to allow many patients to continue working, caring for family, and handling their normal responsibilities while receiving medical care.
Dr. Watson provides treatment through his private Norristown office, with telemedicine available throughout Pennsylvania when appropriate.
Many insurance plans are accepted, and affordable direct-pay options are also available. Medication costs can vary depending on the medication, insurance coverage, and pharmacy or specialty-pharmacy benefits.
Visit our insurance and payment information to learn more.
The Changing “Gas Station” Product Landscape
Over the years, products sold through gas stations, smoke shops, vape shops, and online suppliers have evolved. New compounds and increasingly concentrated products—including 7-OH, pseudoindoxyl, MGM products, and others —have appeared alongside traditional kratom products.
Federal regulators have begun taking action against several of these compounds, and some have already been temporarily placed into Schedule I.
For people who had been relying on these products—whether to manage a substance use disorder, withdrawal, pain, or for other reasons—that changing availability may leave them looking for another option.
Established medical treatment for substance use disorder is available.
Dr. Watson has created an educational video library covering addiction, opioid treatment, emerging products, and common questions patients and families ask.
Watch Dr. Watson’s Educational Videos →Recovery Is Getting On With Life.
Effective treatment for substance use disorder should help you get back to living yours.